Ticker

Analyst Price Targets — TTOO

Page 1 • Showing up to 10
DateAnalystFirmTargetPrice @ PostSourceHeadline
July 30, 2024 6:27 amKyle MiksonCanaccord Genuity$5.00$4.74StreetInsider T2 Biosystems, Inc (TTOO) PT Raised to $5 at Canaccord Genuity

Latest News for TTOO

Reviewing T2 Biosystems (NASDAQ:TTOO) & Acutus Medical (NASDAQ:AFIB)

Risk and Volatility Acutus Medical has a beta of -1.28, meaning that its stock price is 228% less volatile than the S&P 500. Comparatively, T2 Biosystems has a beta of 0.88, meaning that its stock price is 12% less volatile than the S&P 500. Profitability This table compares Acutus Medical and T2 Biosystems' net margins,

Defense World • Feb 19, 2026
T2 Biosystems (NASDAQ:TTOO) versus Minerva Surgical (NASDAQ:UTRS) Head-To-Head Review

Valuation and Earnings This table compares Minerva Surgical and T2 Biosystems"s revenue, earnings per share (EPS) and valuation. Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Minerva Surgical $51.69 million 0.00 -$34.11 million ($8.21) 0.00 T2 Biosystems $7.68 million 0.01 -$50.08 million ($3.89) 0.00 Minerva Surgical has higher revenue and earnings than

Defense World • Jan 10, 2026

🧮 Earnings Move Analyzer

Insider Trading

Insider Trading

NameRoleDateTypeSharesPriceFormLink

No Senate trades found for TTOO.

No House trades found for TTOO.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top